Bridge to Life
Bridge to Life Ltd. specializes in organ preservation and perfusion solutions, offering products like Belzer UW® Cold Storage Solution and VitaSmart™ Machine Perfusion System. The company is committed to advancing organ delivery technologies and partners with leading transplant centers globally.
Services
Bridge to Life Ltd. offers a range of organ preservation and perfusion solutions. These include the Belzer UW® Cold Storage Solution, Belzer MPS® UW Machine Perfusion Solution, EasiSlush® Sodium Chloride Solution, French-sized Cannulas & Tubing, and VitaSmart™ Machine Perfusion System. These products are designed for the flushing, cold storage, and perfusion preservation of donor organs such as kidneys, liver, and pancreas. The company serves transplant centers and organ procurement offices globally with advanced technologies to enhance organ delivery, preservation, and revitalization.
Products
Bridge to Life Ltd. provides various products for organ preservation and perfusion. The Belzer UW® Cold Storage Solution is used for the preservation of kidneys, liver, and pancreas organs. The Belzer MPS® UW Machine Perfusion Solution is for in vitro flushing and temporary perfusion preservation of kidneys. The EasiSlush® Sodium Chloride Solution facilitates sterile slush preparation for cooling donor organs during surgery. The VitaSmart™ Machine Perfusion System, pending regulatory clearance, is available in CE Mark-accepting countries. All products aim at preserving organ viability during storage and transport to improve transplantation outcomes.
Corporate Headquarters
Bridge to Life Ltd. is headquartered in Northbrook, IL, with a logistics and ordering office in Columbia, SC. The company's US Corporate Headquarters coordinate activities related to marketing, distribution, and customer support. They work closely with transplant centers and organ procurement organizations to ensure the timely and efficient delivery of organ preservation solutions. Their strategic locations enable them to serve a broad array of clients on a global scale, driving contributions to the organ transplantation community.
Certifications and Quality Assurance
Bridge to Life Ltd. has achieved ISO 13485:2016 certification, demonstrating a strong commitment to quality and safety in organ preservation solutions. This certification underscores their dedication to maintaining high standards in the manufacture and distribution of hypothermic oxygenated perfusion and cold flush organ preservation solutions. By adhering to these stringent quality controls, Bridge to Life Ltd. assures reliability and efficacy in its product offerings, ensuring that more organs can reach recipients in vital health condition.
Research and Development Initiatives
Bridge to Life Ltd. actively participates in research and development to advance organ transplantation technologies. They have announced five accepted abstracts at the 2024 International Congress of the International Liver Transplantation Society (ILTS) and two at the 2024 ELITA Summit by The European Society for Transplantation. They commenced the U.S. pivotal Bridge to HOPE Liver Clinical Trial, focusing on orthotopic liver transplantation. A merger with Tevosol, Inc. has further bolstered their R&D capabilities aimed at developing new organ transplantation products. Their endeavors reflect a continuous effort to innovate within the sector.